EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Foxp3 drives context-dependent epigenetic programs that define regulatory T cell molecular identity and function

Yuxi Wei, Hinako Ago, Ryuichi Murakami, Shotaro Funatsu, Marina Osaki, Akira Nakajima, Yoshinori Hasegawa, Ryoji Kawakami, Shimon Sakaguchi, Shohei Hori

Science Immunology · 2026-05-01 · 11 (119)

DOI: 10.1126/sciimmunol.aed2111 ↗
AbstractBibliografische Angaben

Abstract

Regulatory T cells (T reg cells) express the master regulator, Foxp3, and display distinctive epigenetic landscapes ensuring T reg cell–specific gene expression and stable suppressive functions, yet Foxp3’s contribution to this epigenetic identity remains unclear. Leveraging Foxp3-transduced conventional T cells as a gain-of-function probe in mice, we identified a previously unrecognized subset that acquires endogenous Foxp3 expression, T reg cell–like transcriptomic and chromatin features, and suppressive functions exclusively in vivo. These Foxp3-driven features were conserved in T reg cells but impaired in Foxp3-mutant T reg -like cells, demonstrating a Foxp3 requirement. Induction of endogenous Foxp3 expression in vivo required reduced AKT-mTOR signaling and Foxp3-dependent engagement of STAT5 and nuclear factor κB (NF-κB). Temporal chromatin profiling revealed stepwise Foxp3-driven regulatory programs, including a core program shared across T reg cell subsets and effector-specific programs, both associated with NF-κB activity and Foxp3 binding. Thus, Foxp3 integrates cell-intrinsic and environmental contexts to drive epigenetic programs defining T reg cell identities and functions, with implications for Foxp3-based therapies.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →